Dendreon Perfect Storm

May 2nd, 2009 by Rich

Some analysts forecast Provenge will eventually achieve industry blockbuster status of more than a billion dollars a year in sales.

Provenge is given in three doses over the course of one month. Some patients in the study reported temporary flu-like symptoms after each treatment.

Harvard Medical School professor Dr. Philip Kantoff, one of the study’s lead investigators at the Dana-Farber Cancer Institute, calls the results “significant and incremental,” but says patients should understand that Provenge is a cancer treatment and not a cure.

Dr. Kantoff received a one-time consulting fee from Dendreon a few years ago.

Dendreon CEO Dr. Mitchell Gold says, “Today’s results confirm the potential for Provenge in prostate cancer.”

URL: http://www.cnbc.com/id/30458187/

Pages: 1 2 3 4 5 6

This entry was posted on Saturday, May 2nd, 2009 at 7:38 am and is filed under Money doctor and Counselor. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

 

Leave a Reply